Literature DB >> 30072092

Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Carlotta Giorgi1, Saverio Marchi1, Ines C M Simoes2, Ziyu Ren3, Giampaolo Morciano4, Mariasole Perrone1, Paulina Patalas-Krawczyk2, Sabine Borchard5, Paulina Jędrak6, Karolina Pierzynowska6, Jędrzej Szymański2, David Q Wang7, Piero Portincasa8, Grzegorz Węgrzyn6, Hans Zischka9, Pawel Dobrzyn2, Massimo Bonora10, Jerzy Duszynski2, Alessandro Rimessi1, Agnieszka Karkucinska-Wieckowska11, Agnieszka Dobrzyn12, Gyorgy Szabadkai13, Barbara Zavan14, Paulo J Oliveira15, Vilma A Sardao15, Paolo Pinton16, Mariusz R Wieckowski2.   

Abstract

Aging has been linked to several degenerative processes that, through the accumulation of molecular and cellular damage, can progressively lead to cell dysfunction and organ failure. Human aging is linked with a higher risk for individuals to develop cancer, neurodegenerative, cardiovascular, and metabolic disorders. The understanding of the molecular basis of aging and associated diseases has been one major challenge of scientific research over the last decades. Mitochondria, the center of oxidative metabolism and principal site of reactive oxygen species (ROS) production, are crucial both in health and in pathogenesis of many diseases. Redox signaling is important for the modulation of cell functions and several studies indicate a dual role for ROS in cell physiology. In fact, high concentrations of ROS are pathogenic and can cause severe damage to cell and organelle membranes, DNA, and proteins. On the other hand, moderate amounts of ROS are essential for the maintenance of several biological processes, including gene expression. In this review, we provide an update regarding the key roles of ROS-mitochondria cross talk in different fundamental physiological or pathological situations accompanying aging and highlighting that mitochondrial ROS may be a decisive target in clinical practice.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age-related neurodegenerative disorders; Aging; Anti-ROS intervention; Antioxidant defense; Mitochondria; Mitochondrial dysfunction–related pathologies; ROS

Mesh:

Substances:

Year:  2018        PMID: 30072092      PMCID: PMC8127332          DOI: 10.1016/bs.ircmb.2018.05.006

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  801 in total

1.  Coenzyme Q supplementation protects from age-related DNA double-strand breaks and increases lifespan in rats fed on a PUFA-rich diet.

Authors:  José L Quiles; Julio J Ochoa; Jesús R Huertas; José Mataix
Journal:  Exp Gerontol       Date:  2004-02       Impact factor: 4.032

2.  Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function.

Authors:  G Nagesh Babu; Alok Kumar; Ram Lakhan Singh
Journal:  Neurotox Res       Date:  2010-03-09       Impact factor: 3.911

3.  Autophagy contributes to caspase-independent macrophage cell death.

Authors:  Yue Xu; Sung Ouk Kim; Yilei Li; Jiahuai Han
Journal:  J Biol Chem       Date:  2006-05-15       Impact factor: 5.157

4.  Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage.

Authors:  Giuseppe Paradies; Giuseppe Petrosillo; Marilva Pistolese; Francesca Maria Ruggiero
Journal:  Gene       Date:  2002-03-06       Impact factor: 3.688

5.  Extension of murine life span by overexpression of catalase targeted to mitochondria.

Authors:  Samuel E Schriner; Nancy J Linford; George M Martin; Piper Treuting; Charles E Ogburn; Mary Emond; Pinar E Coskun; Warren Ladiges; Norman Wolf; Holly Van Remmen; Douglas C Wallace; Peter S Rabinovitch
Journal:  Science       Date:  2005-05-05       Impact factor: 47.728

Review 6.  Autophagy in nonalcoholic steatohepatitis.

Authors:  Muhammad Amir; Mark J Czaja
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 3.869

7.  Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  Kyle S McCommis; Wesley T Hodges; Elizabeth M Brunt; Ilke Nalbantoglu; William G McDonald; Christopher Holley; Hideji Fujiwara; Jean E Schaffer; Jerry R Colca; Brian N Finck
Journal:  Hepatology       Date:  2017-03-30       Impact factor: 17.425

8.  Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Authors:  Mazen Noureddin; Katherine P Yates; Ivana A Vaughn; Brent A Neuschwander-Tetri; Arun J Sanyal; Arthur McCullough; Raphael Merriman; Bilal Hameed; Edward Doo; David E Kleiner; Cynthia Behling; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-02       Impact factor: 17.425

Review 9.  Autophagy in disease: a double-edged sword with therapeutic potential.

Authors:  Wim Martinet; Patrizia Agostinis; Barbara Vanhoecke; Michael Dewaele; Guido R Y De Meyer
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

Review 10.  Mitochondria in Huntington's disease.

Authors:  Maria Damiano; Laurie Galvan; Nicole Déglon; Emmanuel Brouillet
Journal:  Biochim Biophys Acta       Date:  2009-08-11
View more
  54 in total

Review 1.  Antimutagenic Activity as a Criterion of Potential Probiotic Properties.

Authors:  Evgeniya V Prazdnova; Maria S Mazanko; Vladimir A Chistyakov; Anna A Bogdanova; Aleksandr G Refeld; Evgeniya Y Kharchenko; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-14       Impact factor: 4.609

2.  Changes in S-(2-succinyl)cysteine and advanced glycation end-products levels in mouse tissues associated with aging.

Authors:  Nana Katsuta; Himeno Takahashi; Mime Nagai; Hikari Sugawa; Ryoji Nagai
Journal:  Amino Acids       Date:  2022-02-15       Impact factor: 3.520

Review 3.  Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke.

Authors:  Meiying Song; Yuan Zhou; Xiang Fan
Journal:  Mol Neurobiol       Date:  2022-03-09       Impact factor: 5.590

4.  Neuroprotective Effects of Chrysin on Diclofenac-Induced Apoptosis in SH-SY5Y Cells.

Authors:  Ekrem Darendelioglu
Journal:  Neurochem Res       Date:  2020-02-10       Impact factor: 3.996

Review 5.  Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan.

Authors:  Raul Castro-Portuguez; George L Sutphin
Journal:  Exp Gerontol       Date:  2020-01-16       Impact factor: 4.032

Review 6.  Mitochondrial Bioenergetics and Dynamism in the Failing Heart.

Authors:  Giampaolo Morciano; Veronica Angela Maria Vitto; Esmaa Bouhamida; Carlotta Giorgi; Paolo Pinton
Journal:  Life (Basel)       Date:  2021-05-12

Review 7.  Mitochondrial Quality Control in Cerebral Ischemia-Reperfusion Injury.

Authors:  Mimi Wu; Xiaoping Gu; Zhengliang Ma
Journal:  Mol Neurobiol       Date:  2021-07-18       Impact factor: 5.590

8.  Annexin A1 Tripeptide Mimetic Increases Sirtuin-3 and Augments Mitochondrial Function to Limit Ischemic Kidney Injury.

Authors:  Hagir Suliman; Qing Ma; Zhiquan Zhang; Jiafa Ren; Benjamin T Morris; Steven D Crowley; Luis Ulloa; Jamie R Privratsky
Journal:  Front Physiol       Date:  2021-07-01       Impact factor: 4.566

9.  Alterations in mitochondrial dynamics with age-related Sirtuin1/Sirtuin3 deficiency impair cardiomyocyte contractility.

Authors:  Jingwen Zhang; Zhibin He; Julia Fedorova; Cole Logan; Lauryn Bates; Kayla Davitt; Van Le; Jiayuan Murphy; Melissa Li; Mingyi Wang; Edward G Lakatta; Di Ren; Ji Li
Journal:  Aging Cell       Date:  2021-07-03       Impact factor: 9.304

10.  Features of age-related response to sleep deprivation: in vivo experimental studies.

Authors:  Maria Novozhilova; Tatiana Mishchenko; Elena Kondakova; Tatiana Lavrova; Maria Gavrish; Svetlana Aferova; Claudio Franceschi; Maria Vedunova
Journal:  Aging (Albany NY)       Date:  2021-07-28       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.